School of Nursing, The University of Texas at Austin, Austin, Texas.
Holon Inclusive Health System & Together Wellness, St. Louis, Missouri.
J Am Assoc Nurse Pract. 2020 Oct;32(10):703-713. doi: 10.1097/JXX.0000000000000499.
This review is intended to guide primary care providers in differentiating patients with bipolar depression from those with unipolar depression and inform patient management. Up to 64% of clinical encounters for depression occur in primary care, with misdiagnosis of bipolar depression common in both primary care and psychiatry. Although bipolar disorder is characterized by manic, hypomanic, and depressive episodes, the most common and debilitating symptomatic presentation is depression. Misdiagnosis as unipolar depression is common, often resulting in mistreatment with an unopposed monoamine antidepressant. Antidepressants are often ineffective for treating bipolar depression and may cause detrimental consequences such as treatment-emergent hypomania/mania, rapid cycling, or increased suicidality. Factors that are suggestive of bipolar disorder versus unipolar depression include early-onset depression, frequent depressive episodes, family history of serious mental illness, hypomania/mania symptoms within the depressive episode, and nonresponse to antidepressants. Comorbid medical (e.g., cardiovascular disease, hypertension, obesity) and psychiatric (e.g., attention-deficit/hyperactivity disorder, anxiety disorder, personality disorders, and substance use disorder) conditions are common and contribute to premature mortality for patients with bipolar disorder compared with the general public. Cariprazine, fluoxetine/olanzapine, lurasidone, and quetiapine are approved to treat bipolar depression; only cariprazine and quetiapine are approved to treat both bipolar mania and depression. Primary care providers who can differentiate presenting symptoms of bipolar depression from unipolar depression and offer appropriate treatment options will optimize patient care in clinical practice. Relevant information for this review was identified through a multistep literature search of PubMed using the terms bipolar depression/bipolar disorder plus other relevant terms.
这篇综述旨在指导初级保健提供者区分双相情感障碍抑郁与单相抑郁患者,并为患者管理提供信息。多达 64%的抑郁临床就诊发生在初级保健中,无论是在初级保健还是精神病学中,双相情感障碍抑郁的误诊都很常见。虽然双相情感障碍的特征是躁狂、轻躁狂和抑郁发作,但最常见和最具致残性的症状表现是抑郁。误诊为单相抑郁很常见,通常导致使用单胺抗抑郁药治疗不当。抗抑郁药通常对治疗双相情感障碍无效,并且可能导致有害后果,如治疗中出现轻躁狂/躁狂、快速循环或自杀风险增加。提示双相情感障碍与单相抑郁的因素包括抑郁发病早、抑郁发作频繁、严重精神疾病家族史、抑郁发作期间出现轻躁狂/躁狂症状、以及对抗抑郁药无反应。共病的医学(如心血管疾病、高血压、肥胖症)和精神疾病(如注意力缺陷多动障碍、焦虑障碍、人格障碍和物质使用障碍)很常见,与普通人群相比,双相情感障碍患者的过早死亡与这些共病有关。卡利拉嗪、氟西汀/奥氮平、鲁拉西酮和喹硫平被批准用于治疗双相情感障碍抑郁;只有卡利拉嗪和喹硫平被批准用于治疗双相躁狂和抑郁。能够区分双相情感障碍抑郁与单相抑郁的表现症状并提供适当治疗选择的初级保健提供者将在临床实践中优化患者护理。本综述相关信息通过在 PubMed 中使用“双相情感障碍/双相障碍”加其他相关术语进行多步骤文献检索确定。